Heartseed (TSE:219A) EV-to-FCF: (As of Jul. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:219A Heartseed Inc TSE:219A
11 GF Score
Price 円1,495.00
View Full Analysis

What is Heartseed EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Heartseed's Enterprise Value is 円27,785 Mil. Heartseed's Free Cash Flow for the trailing twelve months (TTM) ended in Oct. 2025 was 円0 Mil. Therefore, Heartseed's EV-to-FCF for today is .

The historical rank and industry rank for Heartseed's EV-to-FCF or its related term are showing as below:

TSE:219A' s EV-to-FCF Range Over the Past 10 Years
Min: 0   Med: 0   Max: 26.42
Current: 26.42

During the past 4 years, the highest EV-to-FCF of Heartseed was 26.42. The lowest was 0.00. And the median was 0.00.

TSE:219A's EV-to-FCF is ranked worse than
63.61% of 338 companies
in the Biotechnology industry
Industry Median: 15.02 vs TSE:219A: 26.42

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-07-21), Heartseed's stock price is 円1495.00. Heartseed's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Oct. 2025 was 円-25.070. Therefore, Heartseed's PE Ratio (TTM) for today is At Loss.

Heartseed  (TSE:219A) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Heartseed's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1495.00/-25.070
=At Loss

Heartseed's share price for today is 円1495.00.
Heartseed's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Oct. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-25.070.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Heartseed EV-to-FCF Related Terms

Heartseed EV-to-FCF Historical Data

* Premium members only.

The historical data trend for Heartseed's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Heartseed EV-to-FCF Chart

Heartseed Annual Data
Trend Oct22 Oct23 Oct24 Oct25
EV-to-FCF
0.00 0.00 -18.67 31.08

Heartseed Quarterly Data
Oct22 Oct23 Apr24 Jul24 Oct24 Apr25 Jul25 Oct25 Mar26
EV-to-FCF Get a 7-Day Free Trial Premium Member Only -18.67 0.00 0.00 31.08 0.00

TSE:219A vs VRTX, REGN, ALNY: EV-to-FCF Comparison

For the Biotechnology subindustry, Heartseed's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Heartseed EV-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Heartseed's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Heartseed's EV-to-FCF falls into.


TSE:219A
11GF Score
Heartseed Inc TSE:219A
EV-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Heartseed EV-to-FCF Calculation

Heartseed's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=27785.393/0
=

Heartseed's current Enterprise Value is 円27,785 Mil.
Heartseed's Free Cash Flow for the trailing twelve months (TTM) ended in Oct. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Heartseed Business Description

Address 1-2-3 Shibaura, Minato-ku, Tokyo, JPN, 105-0023
Heartseed Inc is a Japanese biotechnology company focused on developing and commercializing regenerative medicine treatments for severe heart failure. The company's product candidate, HS-001, involves transplanting clusters of purified heart muscle cells derived from iPSCs to the patient's heart to treat heart failure, especially Heart Failure with reduced Left Ventricular Ejection Fraction (HFrEF), including conditions such as Dilated Cardiomyopathy, Old Myocardial Infarction, and Dilated phase of Hypertrophic Cardiomyopathy.
11GF Score

Get the complete analysis for TSE:219A

EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,495.00
Price